RiceBran Technologies (NASDAQ:RIBT) is reporting third quarter earnings results on Thursday 5th November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.07 per share from $ 5.89 million in revenue.
For the full year, analysts predict revenues of $ 27.78 million, while looking forward to loss of $ 0.29 per share.
Previous Quarter Performance
RiceBran Technologies unfold loss for the second quarter of $ 0.10 per share, from the revenue of $ 5.90 million. The quarterly revenues fell 5.14 percent compared with the same quarter last year. Street analysts expected RiceBran Technologies to report loss of $ 0.06 per share on revenue of $ 9.05 million for the second quarter. The bottom line results missed street analysts by $ 0.04 or 66.67 percent, at the same time, top line results fell short of analysts by $ 3.15 million or 34.81 percent.
Stock Performance
Shares of RiceBran Technologies traded low $ -0.06 or -11.24 percent on Wednesday, reaching $ 0.47 with volume of 350.00 thousand shares. RiceBran Technologies has traded high as $ 0.55 and has cracked $ 0.45 on the downward trend
The closing price of $ 0.47, representing a 43.24 % increase from the 52 week low of $ 0.37 and a 81.85 % decrease over the 52 week high of $ 2.92.
The company has a market capital of $ 19.02 million and is part of the Consumer Defensive sector and Packaged Foods industry.
RiceBran Technologies processes and markets healthy, natural, and nutrient dense products derived from raw rice bran. The company manufactures and distributes stabilized rice bran (SRB) in various granulations with other products and derivatives. It offers RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich derivative of RiBalance; and protein and protein/fiber blends under the ProRyza brand.
